Ann: Update on non-binding indicative proposal, page-19

First 19 Last

Share
Profile

Follow
peony-rose

2,853 Posts.

139

07/06/21

12:20

Post #: 53690081
Share

Originally posted by yanzifeisheng: ↑

This thing isn't worth $2...

There are too many beds/places in Australia.. there was a huge building boom in the industry when everyone thought the RADs were free capital, so Sudholz and others were going around saying ROIC on development is infinite....So occupancy unlikely to go up substantially - see slide 19 of JHC's 1H 2021 result presentation for the trend.

Government has twigged that care at home is the best outcome for itself (see increase to Home Care Package funding) and families don't want to fork out the egregious fees in a nursing home.

These facilities residents' average age is 85, average length of stay is just over 2 years... people typically only send a parent to one of these facilities when they become incontinent, or they're immobile. Definitely not a river of gold like these stocks were all billed at their IPOs... it's a commodity real estate play with complicated staffing and regulatory operations.

However... the house price boom should send these companies up another leg in valuation over the next 5 years. RADs, and the land value of the facilities themselves, are all linked to residential real estate prices....

Would think ~A$1.40 ceiling if there's a bidding war... but Calvary is not-for-profit... and the synergies aren't huge, only head office costs and minor savings on procurement, so unlikely to see a huge acquisition premium.

Expand

Are you taking in to account the aging population and also rising rates of dementia?

JHC Price at posting: $1.18 Sentiment: Hold Disclosure: Held
1 Upvote

0 Great analysis

Reply

Top Stories

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

FFM

Firefly positioned for copper growth in Canada ahead of resource update

CC9

Chariot Corp unveils plans for Black Mountain "pilot mine" in Wyoming, US; shares jump +20%

RCE

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

There are more pages in this discussion • 93 more messages in this thread...

First 19 Last

Add JHC (ASX) to my watchlist

Ann: Update on non-binding indicative proposal, page-19

Top Stories

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Firefly positioned for copper growth in Canada ahead of resource update

Chariot Corp unveils plans for Black Mountain "pilot mine" in Wyoming, US; shares jump +20%

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Featured News